rxstat › Shortages › Alprostadil
Alprostadil shortage status
Widespread shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Alprostadil is in a widespread shortage in Canada. 3 of 5 reported products are affected. Manufacturers have not committed to a recovery date.
In shortage since
Jul 22, 2021
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageMUSE
250MCG · SUPPOSITORY · PALADIN LABS INC.
DIN 02238593 · since ?, no end estimate · Disruption of the manufacture of the drug.
Active shortageMUSE
500MCG · SUPPOSITORY · PALADIN LABS INC.
DIN 02238594 · since Jun 3, 2022, no end estimate · Disruption of the manufacture of the drug.
Active shortageMUSE
1000MCG · SUPPOSITORY · PALADIN LABS INC.
DIN 02238595 · since Jul 22, 2021, no end estimate · Delay in shipping of the drug.
AnticipatedCAVERJECT STERILE POWDER
20MCG · POWDER FOR SOLUTION
LIQUID
KIT · PFIZER CANADA ULC
DIN 02215756 · Disruption of the manufacture of the drug.
ResolvedCAVERJECT STERILE POWDER
20MCG · POWDER FOR SOLUTION
LIQUID
KIT · PFIZER CANADA ULC
DIN 02215756 · ended May 14, 2024 · Disruption of the manufacture of the drug.
ResolvedPROSTIN VR STERILE SOLUTION
500MCG · SOLUTION · PFIZER CANADA ULC
DIN 00559253 · ended Dec 8, 2023 · Disruption of the manufacture of the drug.
ResolvedPROSTIN VR STERILE SOLUTION
500MCG · SOLUTION · PFIZER CANADA ULC
DIN 00559253 · ended May 12, 2022 · Disruption of the manufacture of the drug.
ResolvedMUSE
250MCG · SUPPOSITORY · PALADIN LABS INC.
DIN 02238593 · ended Mar 22, 2022 · Disruption of the manufacture of the drug.
ResolvedMUSE
500MCG · SUPPOSITORY · PALADIN LABS INC.
DIN 02238594 · ended Feb 11, 2022 · Delay in shipping of the drug.
ResolvedMUSE
250MCG · SUPPOSITORY · PALADIN LABS INC
DIN 02238593 · ended Apr 28, 2021 · Delay in shipping of the drug.
ResolvedMUSE
1000MCG · SUPPOSITORY · PALADIN LABS INC
DIN 02238595 · ended Mar 26, 2021 · Delay in shipping of the drug.
ResolvedCAVERJECT STERILE POWDER
23.2MCG · KIT
LIQUID
POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02215756 · ended Oct 26, 2020 · Disruption of the manufacture of the drug.
Showing 12 of 19 reports. All reports are on file with Health Canada.
What's happening
Alprostadil is currently affected by 3 active shortage reports filed with Health Canada by PALADIN LABS INC..
The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Alprostadil is classified under “OTHER UROLOGICALS, INCL ANTISPASMODICS” (ATC G04BE).
Recent changes
Common questions
When will Alprostadil be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Alprostadil in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All other urologicals, incl antispasmodics shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.